These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 18453273)

  • 21. Biofilms on central venous catheters: is eradication possible?
    Donlan RM
    Curr Top Microbiol Immunol; 2008; 322():133-61. PubMed ID: 18453275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biofilm-specific antibiotic tolerance and resistance.
    Olsen I
    Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):877-86. PubMed ID: 25630538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical significance and new therapeutical strategies for biofilm associated infections.
    Lazăr V; Chifiriuc MC
    Roum Arch Microbiol Immunol; 2010; 69(3):125-38. PubMed ID: 21434589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biofilm-specific antibiotic resistance.
    Mah TF
    Future Microbiol; 2012 Sep; 7(9):1061-72. PubMed ID: 22953707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is combined medication with natural medicine a promising therapy for bacterial biofilm infection?
    Zhang L; Liang E; Cheng Y; Mahmood T; Ge F; Zhou K; Bao M; Lv L; Li L; Yi J; Lu C; Tan Y
    Biomed Pharmacother; 2020 Aug; 128():110184. PubMed ID: 32450528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial biofilm infections, their resistance to antibiotics therapy and current treatment strategies.
    Singh A; Amod A; Pandey P; Bose P; Pingali MS; Shivalkar S; Varadwaj PK; Sahoo AK; Samanta SK
    Biomed Mater; 2022 Feb; 17(2):. PubMed ID: 35105823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria.
    Kester JC; Fortune SM
    Crit Rev Biochem Mol Biol; 2014; 49(2):91-101. PubMed ID: 24328927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of biofilm stimulation by subinhibitory concentrations of antimicrobials.
    Ranieri MR; Whitchurch CB; Burrows LL
    Curr Opin Microbiol; 2018 Oct; 45():164-169. PubMed ID: 30053750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of quorum-sensing blockers as therapeutic agents for the control of biofilm-associated infections.
    Rice SA; McDougald D; Kumar N; Kjelleberg S
    Curr Opin Investig Drugs; 2005 Feb; 6(2):178-84. PubMed ID: 15751741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biofilms: microbes and disease.
    Aparna MS; Yadav S
    Braz J Infect Dis; 2008 Dec; 12(6):526-30. PubMed ID: 19287843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action.
    Roy R; Tiwari M; Donelli G; Tiwari V
    Virulence; 2018 Jan; 9(1):522-554. PubMed ID: 28362216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Big Impact of the Tiny: Bacteriophage-Bacteria Interactions in Biofilms.
    Hansen MF; Svenningsen SL; Røder HL; Middelboe M; Burmølle M
    Trends Microbiol; 2019 Sep; 27(9):739-752. PubMed ID: 31128928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond antibiotics: CRISPR/Cas9 triumph over biofilm-associated antibiotic resistance infections.
    Zuberi A; Ahmad N; Ahmad H; Saeed M; Ahmad I
    Front Cell Infect Microbiol; 2024; 14():1408569. PubMed ID: 39035353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combating chronic bacterial infections by manipulating cyclic nucleotide-regulated biofilm formation.
    An SQ; Ryan RP
    Future Med Chem; 2016 Jun; 8(9):949-61. PubMed ID: 27304227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria.
    Wong JP; DiTullio P; Parkinson S
    Future Microbiol; 2015; 10(11):1751-8. PubMed ID: 26597426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-biofilm peptides as a new weapon in antimicrobial warfare.
    Pletzer D; Coleman SR; Hancock RE
    Curr Opin Microbiol; 2016 Oct; 33():35-40. PubMed ID: 27318321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bactericidal, quorum quenching and anti-biofilm nanofactories: a new niche for nanotechnologists.
    Singh BN; Prateeksha ; Upreti DK; Singh BR; Defoirdt T; Gupta VK; De Souza AO; Singh HB; Barreira JC; Ferreira IC; Vahabi K
    Crit Rev Biotechnol; 2017 Jun; 37(4):525-540. PubMed ID: 27684212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural antimicrobial peptide complexes in the fighting of antibiotic resistant biofilms: Calliphora vicina medicinal maggots.
    Gordya N; Yakovlev A; Kruglikova A; Tulin D; Potolitsina E; Suborova T; Bordo D; Rosano C; Chernysh S
    PLoS One; 2017; 12(3):e0173559. PubMed ID: 28278280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A growing battlefield in the war against biofilm-induced antimicrobial resistance: insights from reviews on antibiotic resistance.
    Pai L; Patil S; Liu S; Wen F
    Front Cell Infect Microbiol; 2023; 13():1327069. PubMed ID: 38188636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate.
    Mohamed MF; Brezden A; Mohammad H; Chmielewski J; Seleem MN
    Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):848-859. PubMed ID: 28132897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.